RxDoctor Payments Data

Joseph McCracken, MD

Hematology & Oncology · San Antonio, TXNPI 1023022365

Payments from drug & device makers

$6,069in general payments, 2019–2025

Across 18 payments — averaging $337.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$5K
  • Daiichi Sankyo Inc.$550
  • Pharmacyclics LLC, An Abbvie Company$90
  • Lilly USA, LLC$79
  • Eisai Inc.$53
  • Merck$41
  • plus $55 from 3 others

What the payments were for

  • Speaking & faculty fees$55063%
  • Food & beverage$29334%
  • Education$263%

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,069 in reported general payments places this provider in the 45th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Medicare billing

Part B allowed, 2024
$16,749
Medicare patients
104
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$10,793

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →